ProQR Therapeutics NV (PRQR) - Financial and Strategic SWOT Analysis Review

  • ID: 4278569
  • SWOT Analysis
  • 25 pages
  • GlobalData
1 of 4
Summary

ProQR Therapeutics NV (ProQR) is a biotech company that discovers and develops drugs for the treatment of genetic disorders. The company’s lead product candidate includes QR-010, a RNA-based oligonucleotide used for the treatment of cystic fibrosis; QR-110, an oligonucleotide that is designed to treat Leber's congenital amaurosis; and QR-313, a single-stranded oligonucleotide used for the treatment of epidermolysis bullosa. It also develops drugs for the treatment of usher syndrome, fuchs endothelial corneal dystrophy, dystrophic epidermolysis bullosa, alzheimer's disease, central nervous system and neuromuscular diseases. The company operates through its laboratory and offices located in Leiden. The company has additional office in Palo Alto, the US. ProQR is headquartered in Leiden, the Netherlands.

ProQR Therapeutics NV Key Recent Developments

Feb 28, 2018: ProQR Announces Results for the Fourth Quarter and Full Year 2017 and Provides Business Update
Feb 06, 2018: ProQR to Present at Upcoming Scientific Meeting and Investor Conference
Nov 20, 2017: ProQR Announces Results for the Third Quarter of 2017
Nov 09, 2017: ProQR Appoints Thaddeus Dryja, M.D. to Scientific Advisory Board
Oct 31, 2017: ProQR to Present at EuroTIDES Conference

This comprehensive SWOT profile of ProQR Therapeutics NV provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the author’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, the author’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of ProQR Therapeutics NV including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
*Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
Section 1 - About the Company
  • ProQR Therapeutics NV - Key Information
  • ProQR Therapeutics NV - Overview
  • ProQR Therapeutics NV - Key Employees
  • ProQR Therapeutics NV - Key Employee Biographies
  • ProQR Therapeutics NV - Key Operational Heads
  • ProQR Therapeutics NV - Major Products and Services
  • ProQR Therapeutics NV - History
  • ProQR Therapeutics NV - Company Statement
  • ProQR Therapeutics NV - Locations And Subsidiaries
  • ProQR Therapeutics NV - Key Manufacturing facilities
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • ProQR Therapeutics NV - Business Description
  • ProQR Therapeutics NV - Corporate Strategy
  • ProQR Therapeutics NV - SWOT Analysis
  • SWOT Analysis - Overview
  • ProQR Therapeutics NV - Strengths
  • ProQR Therapeutics NV - Weaknesses
  • ProQR Therapeutics NV - Opportunities
  • ProQR Therapeutics NV - Threats
  • ProQR Therapeutics NV - Key Competitors
Section 3 - Company Financial Performance Charts
  • ProQR Therapeutics NV - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Appendix
  • Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
*Note: Some sections may be missing if data is unavailable for the company

List of Tables
  • ProQR Therapeutics NV, Key Information
  • ProQR Therapeutics NV, Key Ratios
  • ProQR Therapeutics NV, Share Data
  • ProQR Therapeutics NV, Major Products and Services
  • ProQR Therapeutics NV, History
  • ProQR Therapeutics NV, Key Employees
  • ProQR Therapeutics NV, Key Employee Biographies
  • ProQR Therapeutics NV, Key Operational Heads
  • ProQR Therapeutics NV, Other Locations
  • ProQR Therapeutics NV, Subsidiaries
  • ProQR Therapeutics NV, Key Manufacturing facilities
  • ProQR Therapeutics NV, Key Competitors
  • ProQR Therapeutics NV, SWOT Analysis
  • ProQR Therapeutics NV, Ratios based on current share price
  • ProQR Therapeutics NV, Annual Ratios
  • ProQR Therapeutics NV, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • ProQR Therapeutics NV, Performance Chart
  • ProQR Therapeutics NV, Ratio Charts
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll